Skip to main content
    M

    MAIA Biotechnology Inc. (MAIA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.24
    +0.23 (+22.77%)

    Market Cap: $61.75M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    MAIA Biotechnology Inc. (MAIA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    MAIA Biotechnology (MAIA) has a market cap of $61.75M and an enterprise value of $40.41M. Its share count is up 83.32% from a year earlier. It holds $21.34M more cash than debt, 34.56% of its market cap.

    Total Valuation

    Enterprise value is 34.56% below the market cap, as cash exceeds debt.

    Market Cap$61.75M
    Enterprise Value$40.41M
    Latest price (Nov 17, 2026)$1.24

    Key Dates

    The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 22, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.12% in the quarter ended Sep 30, 2026 and grew 59.60% a year over 2 years.

    Shares Outstanding60.86M
    Shares Change (YoY)+83.32%
    Shares Change (QoQ)+0.12%
    Share Count Growth (2Y CAGR)+59.60%

    Price Statistics

    The stock is up 19.23% over 52 weeks and trades 5.08% above its 50-day average.

    Beta (1Y)1.50
    52-Week Change+19.23%
    1-Month Change+15.89%
    3-Month Change-10.79%
    6-Month Change+0.81%
    Total Return (1Y)+19.23%
    Total Return (3Y CAGR)+0.82%
    Return vs SPY (1Y)+11.21%
    Max Drawdown (1Y)-66.10%
    Max Drawdown (3Y)-82.92%
    Sharpe Ratio (1Y)0.23
    Correlation with SPY (1Y)0.23
    50-Day Average$1.18
    200-Day Average$1.38
    52-Week Range$0.87 to $3.19
    RSI (14 Days)61.0
    Average Volume (20 Days)330.74K

    Price chart

    Financial Position

    Current assets cover 3.41x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio3.41x
    Quick Ratio3.41x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -171.24% and return on assets is -113.66% over the last 12 months.

    Return on Equity (ROE)-171.24%
    Return on Assets (ROA)-113.66%

    Scores

    MAIA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$27.61M
    Pretax Income-$25.12M
    Net Income-$25.12M
    Reported EPS (TTM)-$0.53

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 66.38% of the $22.10M in total assets.

    Cash and Equivalents$21.34M
    Total Debt$0
    Net Cash$21.34M
    Net Cash Per Share$0.35
    Working Capital$15.62M
    Shareholder Equity$14.67M
    Book Value Per Share$0.24
    Total Assets$22.10M
    Total Liabilities$7.43M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$25.39M
    FCF Per Share-$0.41

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+62.22%
    Tangible Book Per Share Growth (2Y CAGR)+62.22%

    Revenue and profit by year

    Dividends and Yields

    MAIA does not pay a dividend.

    Buyback Yield-47.53%
    Shareholder Yield-47.53%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About MAIA

    What is MAIA's market cap?

    MAIA Biotechnology has a market cap of $61.75M. Its enterprise value, which adds debt and subtracts cash, is $40.41M.

    How many shares of MAIA are outstanding?

    MAIA Biotechnology has 60.86M shares outstanding. The count is up 83.32% from a year earlier.

    Does MAIA pay a dividend?

    No. MAIA Biotechnology does not pay a dividend.

    How much debt does MAIA have?

    MAIA Biotechnology has $0 of total debt and $21.34M of cash and equivalents, a net cash position of $21.34M.